Work

Lecanemab and APOE Genotyping in Clinical Practice—Navigating Uncharted Terrain

Year: 2023

Type: article

Abstract: This Viewpoint discusses the findings of the Clarity AD trial, which studied lecanemab for patients with early-stage Alzheimer disease.

Source: JAMA Neurology

DOI: 10.1001/jamaneurol.2023.0207

Authors: Madhav Thambisetty, Robert Howard

Institutions: National Institute on Aging, University College London

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: George Washington University, National Institute for Health and Care Research

OpenAlex ID: W4324020258

FWCI: 1.297

Cites: 6

Cited by: 9

Related to: 10